Personalizing
Cancer Treatment for Everyone

IN THE NEWS

Expert Discusses Radiation Techniques, Genomic Testing in Prostate Cancer

Since the emergence of new data released in 2017, moderate hypofractionation has proven to be a quicker and efficacious method to administer radiation therapy to patients with prostate cancer.

 

Genetic Testing Becoming More Widespread in Ovarian Cancer, But Challenges Remain

Testing for genetic alterations has become an important step in the treatment of patients with ovarian cancer. Although much has been achieved, says Mike Janicek, MD, there needs to be more widespread use of genetic testing in order to push the field forward.

Latest clinical evidence and further development of PARP inhibitors in ovarian cancer

For several decades, the systemic treatment of ovarian cancer has involved chemotherapy, with the relatively recent addition of anti-angiogenic strategies given with chemotherapy and in the maintenance setting. In the past decade, numerous poly(ADP-ribose) polymerase (PARP)-inhibiting agents have been assessed.

 

How can we stop fat cells from fueling cancer?

Cancer cells constantly grow and divide, which means that they need a consistent energy supply. A new study looks at how cancer derives fuel from fat cells and finds a potential mechanism to starve the tumor of its nutrition.

 

Does talcum powder cause cancer? A legal and scientific battle rages

Visitors who walk into Deborah Giannecchini's ranch house in Modesto, California, will notice a well-tended garden, four small dogs who greet every visitor with enthusiasm and a sign that hangs prominently displayed in her living room that reads "It's never too late to live happily ever after."

Cancer risk rises as patients wait for diagnostic testing

Literature review finds increased risk of cancer, late stage cancer, and mortality with increasing wait time between a positive screening and start of diagnostic testing

 

New Drug Combo Improves Survival of Women with Rare Uterine Cancer

Adding the monoclonal antibody drug trastuzumab—already used to treat certain breast cancers—to the chemotherapy regimen of women with a rare form of uterine cancer lengthens the amount of time their tumors are kept from growing, according to Johns Hopkins Medicine researchers conducting a small phase II trial of the regimen, testing its safety and value.

A Remarkable New Technology That Will Diminish A Global Cancer Threat

We in the rich societies of the world don’t hear a lot about aflatoxin. It is probably one of the single largest causes of cancer in the developing world – particularly in Africa.

Immunotherapy Offering New Approach To Treating Cancer

Traditionally, doctors have looked at where a cancer is coming from — lung, bowel, uterus, and so on — to target therapy. But, a new approach has come about in the last few years with medicines called immunotherapy.

New approach for hard-to-treat BRCA breast cancer shrinks tumours twice as fast

Scientists have expressed optimism for women with hard-to-treat breast cancer after a new chemotherapy regime proved it can shrink tumours twice as fast as normal methods.

 

Detecting Breast Cancer with a Deep Learning

Breast cancer is the most common invasive cancer in women, and the second main cause of cancer death in women, after lung cancer. In this article I will build a WideResNet based neural network to categorize slide images into two classes, one that contains breast cancer and other that doesn’t using Deep Learning Studio

Stay in Touch with Us

To speak with a dedicated cancer care specialist, contact us by one of the options listed below:

PLEASE FILL OUT FORM BELOW

X
Talk to Cancer Care Experts
Talk to Cancer Care Experts:
+1 (844) 627-7246
Top